Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus

By O. Pech, A. Behrens, A. May, L. Nachbar, L. Gossner, T. Rabenstein, H. Manner, E. Guenter, J. Huijsmans, M. Vieth and 2 more. Gut, 2008

699 citations recorded by the source corpus.

Subfields: Gastroenterology, Surgery

View Paper: https://www.semanticscholar.org/paper/2ee40029d65c138402b4fcb7eaf00c36b1b13d47

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Surgery

1. Peter D. Siersema

Citations in the corpus

• Esophageal cancer. (2008, background): “Recently, 5-year follow-up data of 349 patients—61 patients who had HGIN and 288 who had mucosal EAC (173 SSBE and 176 LSBE) from a total of 486 patients presenting with Barrett’s neoplasia—were reported.(42) Patients who had submucosal or more advanced EAC were excluded.”
• Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline (2015, positive): “In instances where piecemeal tumor resection was predicted, local recurrence rates were significantly lower with ESD compared with EMR [76].”